• 1

    American Diabetes Association: Consensus Development Conference on Diabetic Foot Wound Care. .Diabetes Care 22::1354. ,1999. .

  • 2

    Drug treatment protocols: management of foot ulcers in patients with diabetes. .J Am Pharm Assoc (Wash) 40::467. ,2000. .

  • 3

    Bergstrom N, Bennett MA, Carlson CE, et al: Clinical Practice Guideline Number 15: Treatment of Pressure Ulcers. AHCPR publication 95-0652. US Dept of Health and Human Services, Agency for Health Care Policy and Research, Rockville, MD, 1994..

  • 4

    Dorland’s Illustrated Medical Dictionary, 28th Ed, WB Saunders, Philadelphia, 1994..

  • 5

    Wound Consultants Inc: WCI Manual, Denver, 1998..

  • 6

    Goebel RH, Goebel MR: Clinical practice guidelines for pressure ulcer prevention can prevent malpractice lawsuits in older patients. .J Wound Ostomy Continence Nurs. 26::175. ,1999. .

    • PubMed
    • Search Google Scholar
    • Export Citation

Standardizing Wound Treatment Procedures for Advanced Technologies

Gerit D. Mulder Director of Research and Education, Clinical Director, University of California San Diego Medical Center, Regional Burn Center/Wound Treatment and Research Center, 200 W Arbor Dr 8896, San Diego, CA 92103-8896.

Search for other papers by Gerit D. Mulder in
Current site
Google Scholar
PubMed
Close
 DPM, MS

New drugs and tissue replacements are currently being approved and integrated into treatment regimens for chronic wounds. This article focuses on a standardized procedure for the use of specific growth factor, a recombinant human platelet-derived growth factor (rhPDGF-BB) manufactured for topical administration. The recommendations made in this article may not reflect product recommendations made by the manufacturer of the drug. Clinicians must be able to support any off-label indication for use of a product. (J Am Podiatr Med Assoc 92(1): 7-11, 2002)